[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Assertio Therapeutics Inc (ASRT)

Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 145,017
  • Shares Outstanding, K 6,445
  • Annual Sales, $ 118,710 K
  • Annual Income, $ -30,380 K
  • EBIT $ 10 M
  • EBITDA $ 41 M
  • 60-Month Beta 0.44
  • Price/Sales 1.21
  • Price/Cash Flow 1,368.18
  • Price/Book 1.53

Options Overview Details

View History
  • Implied Volatility 120.15% (+9.71%)
  • Historical Volatility 54.38%
  • IV Percentile 22%
  • IV Rank 15.55%
  • IV High 748.29% on 12/23/25
  • IV Low 4.53% on 04/16/26
  • Expected Move (DTE 5) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 5
  • Volume Avg (30-Day) 16
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 5,287
  • Open Int (30-Day) 5,335
  • Expected Range 22.50 to 22.50

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-1.91
  • Number of Estimates 1
  • High Estimate $-1.91
  • Low Estimate $-1.91
  • Prior Year $-2.10
  • Growth Rate Est. (year over year) +9.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.01 +24.93%
on 04/22/26
22.55 -0.22%
on 05/08/26
+4.09 (+22.22%)
since 04/08/26
3-Month
11.05 +103.62%
on 03/03/26
22.55 -0.22%
on 05/08/26
+9.76 (+76.61%)
since 02/06/26
52-Week
8.61 +161.32%
on 12/31/25
22.55 -0.22%
on 05/08/26
+12.91 (+134.59%)
since 05/08/25

Most Recent Stories

More News
Assertio and Garda Mutually Agree to Delay Launch of Tender Offer

Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), today announced that it has reached a mutual agreement with Garda Therapeutics, Inc. (“Garda”) to delay the launch of the...

ASRT : 22.50 (+0.58%)
Assertio and Garda Mutually Agree to Postpone Commencement of Tender Offer

Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), today announced that it has reached a mutual agreement with Garda Therapeutics, Inc. (“Garda”) to postpone the commencement...

ASRT : 22.50 (+0.58%)
Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics

Increased All-Cash Tender Offer Price of $21.80 per share – or $153.2 Million New Tender Offer Price Represents 21.1% Premium to Prior Offer

ASRT : 22.50 (+0.58%)
Assertio and Garda Mutually Agree to Extend Tender Offer Deadline

Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), today announced that it has reached a mutual agreement with Garda Therapeutics, Inc. (“Garda”) to extend the deadline to...

ASRT : 22.50 (+0.58%)
Assertio Provides Update on Garda Therapeutics Tender Process

Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), today provided an update that Garda Therapeutics, Inc. (“Garda”) intends to commence the tender offer to acquire all outstanding...

ASRT : 22.50 (+0.58%)
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--WSR, ASRT, EHAB, and SEM

NEW YORK , April 15, 2026 /PRNewswire/ --

EHAB : 13.79 (+0.15%)
WSR : 18.98 (+0.11%)
ASRT : 22.50 (+0.58%)
SEM : 16.41 (-0.18%)
Are AVNS, LEG, ASRT Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

AVNS : 24.80 (+0.12%)
ASRT : 22.50 (+0.58%)
LEG : 10.06 (-2.33%)
Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Assertio Holdings ...

ASRT : 22.50 (+0.58%)
ASRT Stock Alert: Halper Sadeh LLC is Investigating Whether Assertio Holdings, Inc. is Obtaining a Fair Price for its Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that could limit superior...

ASRT : 22.50 (+0.58%)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Assertio Holdings, Inc. (NASDAQ: ASRT)

NEW YORK , April 9, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

ASRT : 22.50 (+0.58%)

Business Summary

Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc.,...

See More

Key Turning Points

3rd Resistance Point 22.73
2nd Resistance Point 22.64
1st Resistance Point 22.57
Last Price 22.50
1st Support Level 22.41
2nd Support Level 22.32
3rd Support Level 22.25

See More

52-Week High 22.55
Last Price 22.50
Fibonacci 61.8% 17.22
Fibonacci 50% 15.58
Fibonacci 38.2% 13.94
52-Week Low 8.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.